Technologies showcased at the 2025 Osaka Expo,?including a sheet of heart muscle cells made from induced pluripotent stem (iPS) cells,?are seeing growing practical applications.
Patients with ischemic cardiomyopathy, in which clogged blood vessels prevent the heart muscle from functioning properly, need to receive a heart transplant when the condition becomes serious. In many cases, they need to wait for over five years before receiving a transplant.
But if three of Cuorips’?RiHeart iPS cell-based sheets are attached to a heart, some 100 million cardiomyocytes promote blood vessel recovery, helping improve the heart’s function.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.